To evaluate the age-adjusted Framingham risk score (AFRS), flow-mediated dilation (FMD) and brachial-ankle pulse wave velocity (baPWV) for the prediction of the coronary heart disease (CHD) in patients with stable angina.
oronary heart disease (CHD) continues to be a leading cause of morbidity and mortality among adults. The Framingham heart study has contributed to the identification of CHD and has developed multivariable functions to predict absolute CHD risk. Wilson et al reported a simple coronary disease prediction algorithm for an ageadjusted Framingham risk score (AFRS) using categorical variables including age, sex, blood pressure, total cholesterol, high-density lipoprotein (HDL), cigarette smoking and diabetes. 1 This algorithm allows physicians to predict multivariate CHD risk in patients who display without overt CHD. Flow-mediated dilation (FMD) represents vascular endothelial function 2 and brachial-ankle pulse wave velocity (baPWV) reflects arterial distensibility. 3 These methods have been widely used in clinical settings because they are non-invasive and are good surrogate markers of preclinical atherosclerosis and vascular damage. 3-5
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The aim of the present study was to evaluate the interrelationship between AFRS and these non-invasive markers of atherosclerosis (FMD and baPWV) in patients with stable angina. We also evaluated the predictive power of AFRS, FMD and baPWV for the prediction of the CHD in the study patients.
Methods

Study Population
Patients were eligible for enrollment if they were aged >30 and <75 years, had stable angina pectoris by history taking or stress test, and were scheduled to undergo coronary angiography (CAG). Patients were excluded if they had a history of PARK KH et al.
acute coronary syndrome, significant valvular heart disease (more than moderate degree), left ventricular dysfunction (left ventricular ejection fraction <55%), ankle-brachial index (ABI) <0.9, atrial fibrillation, chronic kidney disease, or an inability to follow the protocol.
The assessment of baPWV and FMD were done on the morning of the planned CAG. The baPWV was measured before FMD. The patients were instructed not to exercise, or to ingest substances that might affect baPWV and FMD such as caffeine, foods, tobacco, or vasoactive medication for at least 12 h before the study. The studies were done in a quiet, temperature controlled room. In this study, CHD was defined as lumen diameter stenosis >50% in 1 ≥ major coronary artery as determined by CAG. The CAG was interpreted by 1 cardiologist (Y.-J.C.) who was blinded to the patients' clinical data.
Assessment of Pulse Wave Velocity
The baPWV was measured using a volume-plethysmographic apparatus (VP-2000, Colin Co, Komaki, Japan). The reliability of the equipment and the reproducibility of obtained measurements have been validated in previous clinical studies. 6, 7 Cuffs were connected to both plethysmographic and oscillometric sensors, with placement around both arms and ankles while the participant remained in the supine position. The electrocardiogram electrodes were placed on both wrists and a microphone for detecting heart sounds was placed on the left edge of the sternum to detect the second heart sound. The time interval between the wave front of the brachial waveform and that of the ankle waveform was defined as the time interval between the brachium and ankle (DTba). The distance between sampling points of baPWV was calculated automatically according to the height of the patient. The path length from the suprasternal notch to the brachium (Lb) was obtained from superficial measurements and was expressed using the following equation: Lb = [0.2195 × height of the subject (in cm) -2.0734]. The path length from the suprasternal notch to the ankle (La) was obtained from superficial measurements and was expressed using the following equation: La = [0.8129 × height of the subject (in cm) +12.328]. Finally, the following equation was used to obtain baPWV: baPWV = [(La -Lb)/ DTba]. In this study, the left side baPWV was used for the analyses.
Measurement of FMD
An experienced vascular sonographer who was blinded to the patients' information performed an ultrasound examination using a Vivid 7 ultrasound system (GE Vingmed Ultrasound, Horten, Norway) with a 12-MHz linear array transducer. FMD was measured according to the recommendations of Coretti et al. 2 In brief, a landmark 10 cm above the proximal wrist crease of the left radial artery (RA) was used for the ultrasound measurement location. The baseline diameter of the RA was measured from 2-dimensional gray scale longitudinal images. Subsequently, a blood pressure cuff was inflated at the forearm up to 220 mmHg for 5 min. After cuff release, the RA diameter was measured at 1, 2 and 3 min. All of the images were recorded digitally by capturing the RA in the longitudinal plane with an electrocardiogram. One cardiologist (M.-K.K.), who was blinded to the participants' clinical data, interpreted the ultrasound results with an off-line method. The maximal RA diameter image for analysis was chosen around the T-wave on the electrocardiogram. Measurements were taken at 7 points, and the maximal and minimal values were discarded. The mean value from these 5 measurements was used for further analysis. Intra-(M.-K.K.) and interobserver (M.-K.K. and W.J.P.) variability of FMD were calculated in 30 patients by plotting the patient estimates of FMD from each measurement against the estimates by 2 independent measurements. The standard error of the estimate was calculated using this plot. The intra-and interobserver variability was 5.6% and 6.1%.
AFRS
Although the Framingham risk score for CHD has been computed in a variety of different ways since it was first presented, we used the version described by Wilson et al that reported AFRS. This version divides the participant's Framingham risk score by the estimated average risk of the same age group, thus providing the relative risk of the 10-year CHD. 1 In patients who had been treated for dyslipidemia prior to the study, we used the previous data (total cholesterol and HDLcholesterol) before initiation of dyslipidemia therapy.
Statistical Analysis
The continuous variables were summarized as mean ± SD. Categorical variables were presented as numbers or percentages. Least squares linear regression was used to evaluate the association between the AFRS and FMD with baPWV. Multivariate logistic regression analysis was performed to assess independent risk predictors for significant CHD. Because AFRS includes the age, sex, smoking, cholesterol, blood pres- Software, Mariakerke, Belgium). While the FMD and baPWV are the single parameters, AFRS is a complex parameter that includes several important risk factors of CHD. We also evaluated the ROC analysis to determine whether there is additional advantage to combined complex parameters (AFRS plus iFMD, AFRS plus baPWV, and AFRS plus iFMD plus baPWV) over AFRS alone. The value of baPWV/1,000 was used for the complex parameters to create single digits. A probability value <0.05 was considered statistically signifi- cant. This study was approved by the institutional review board of the local center, and all patients gave their written informed consent.
Results
In total, 152 consecutive patients were assessed for the study. Of these, 9 patients with LV dysfunction, and 5 patients with ABI <0.9 were excluded, leaving 138 participants enrolled in the study. The clinical characteristics of the study participants are shown in Table 1 . A total of 71 patients had CHD on CAG. The FMD showed significant inverse correlation with AFRS (r=-0.43, P<0.01) and the baPWV was significantly correlated with AFRS (r=0.41, P<0.01; Figure 1 ). The multivariate logistic regression analysis showed that both AFRS and FMD were independent predictors for CHD (odds ratio (OR) 20.098, 95% confidence interval (CI) 4.773-84.627, P<0.01, and OR 0.865, 95%CI 0.752-0.995, P<0.05, respectively; Table 2 ). In the ROC analysis, the iFMD value was Figure 2 . Receiver operating characteristic curves of AFRS, iFMD, and baPWV for the prediction of coronary heart disease. AFRS, age-adjusted Framingham risk score; baPWV, brachial-ankle pulse wave velocity; iFMD, inverse flow-mediated dilation. Non-Invasive Predictors of CHD
Discussion
The principal findings of this study were that AFRS was a better predictor of CHD than were either FMD or baPWV and that there was no difference in the predictive power between AFRS and combined complex parameters in patients with stable angina. This means that conventional risk factors for the cardiovascular disease do not affect uniformly for atherosclerosis in coronary and peripheral arteries. Ultrasound assessment of FMD is an endothelium-dependent process that reflects the dilation of the artery when it is exposed to increased shear stress due to blood flow. Many studies have shown that endothelial dysfunction is an independent predictor for future cardiovascular events in patients with cardiovascular disease. 8 It provides important prognostic data in addition to the more traditional cardiovascular risk factors, where FMD has been used for evaluating endothelial function. 9-11 Yamashina et al reported that the baPWV could be used as a simple marker of the severity of atherosclerotic vascular damage and cardiovascular risk in the general population. 3 In addition, they demonstrated that the value of baPWV was increased in patients with CHD. 12 Although FMD and baPWV are each reported to have the predictive power for cardiovascular events, comparison of these assessment methods in patients with suspected stable angina has been rare. In the multivariate analysis, FMD was one of the independent predictors of CHD, unlike baPWV. One reason might be that FMD represents early functional changes in the arterial endothelial function and these endothelial changes might appear earlier than the changes in arterial elasticity revealed by baPWV. 13 The Framingham risk score, which is usually used to screen participants without an overt CHD, is a conventional means of predicting the risk of CHD in the general population. 14 A previous study also showed the existence of a strong positive correlation between the Framingham risk score and prevalence of functionally relevant obstructive CHD. 15 In the present study, we used AFRS as an interim expectation of CHD, prior to CAG. FMD showed a significant inverse correlation with AFRS (r=-0.43, P<0.01) and baPWV showed significant correlation with AFRS (r=0.41, P<0.01). After diagnosis of CHD with CAG, a multivariate analysis was performed with AFRS, FMD, baPWV and known risk factors of CHD, such as body mass index, family history of CHD, left ventricular mass index, hsCRP and fibrinogen. AFRS and FMD were independent predictors of CHD. This suggests that AFRS could serve as a strong predictor of CHD, not only in the general population, but also in the patients with stable angina. The decreased FMD value could be one of the predictors of CHD in patients with stable angina. This result agrees with a previous report that impaired FMD is a marker of the preclinical phase of overt CHD. 16 In addition, for patients with impaired FMD, coronary angioplasty and coronary bypass were more often performed than in patients with preserved FMD in suspected angina patients. 17 In this study, the pair wise comparison of the ROC curve showed that AFRS was more powerful than that of iFMD and baPWV in detecting CHD. The reason might be that AFRS is a complex parameter that includes well-known powerful risk factors of CHD such as age, gender, dyslipidemia, diabetes and blood pressure. Therefore, clinicians should always keep in mind the importance of the multifactorial factors of CHD in real clinical settings.
We compared the capacities of AFRS, FMD and baPWV for prediction of CHD. However, the comparison between a complex parameter (AFRS) and single parameters (FMD or baPWV) is somewhat meaningless. Therefore, we also evaluated the ROC analysis to determine whether there is the Figure 3 . Receiver operating characteristic curves of AFRS and combined complex parameters for the prediction of coronary heart disease. AFRS, age-adjusted Framingham risk score; baPWV, brachialankle pulse wave velocity; iFMD, inverse flow-mediated dilation. PARK KH et al.
additional superiority of combining single parameters (iFMD or baPWV) into AFRS. No difference in predictive power was observed between AFRS alone and combined complex parameters (AFRS plus iFMD, AFRS plus baPWV, and AFRS plus iFMD plus baPWV) for detection of CHD. This means that FMD or baPWV measurements might be predictors for the future cardiovascular events but they provided no additional benefit in the diagnosis of CHD in symptomatic stable angina patients. In other words, conventional risk factors for cardiovascular disease do not affect uniformly for atherosclerosis in coronary and peripheral arteries and for arteriosclerosis in larger to middle-sized arteries.
Study Limitations
First, many of the participants were taking anti-hypertensive or anti-anginal medications that might modify indices of FMD and baPWV. Although the patients ceased intake of vasoactive medications 12 h before the study, we could not completely exclude the interaction of these drugs. However, there was no difference of anti-hypertensive or anti-anginal medication between CHD and non-CHD patients (data not shown). In addition, Ghiadoni et al reported that there was no specific effect from main anti-hypertensive drug classes on FMD, except perindopril. 18 Therefore, the effects of the antihypertensive and anti-anginal medication on FMD values thought to be minimal in this study.
Second, one of the major limitations of this study was that the measurement method for the FMD was rather old and the fixed time interval of measurement was somewhat long (1, 2 and 3 min). In addition, we did not use the automated edge detection system that is frequently found in the present day literature. 19 However, according to Corretti et al, nearly 70% of the nitric oxide is released first 60 s after cuff release and most maximal dilation occurs around 1 min after cuff release. 2 In addition, previous and recent studies had given reliable results using the FMD data measured at 60 s. [20] [21] [22] Third, 36 (26%) of our patients had been treated for dyslipidemia before the study. Therefore, we used the data of total-cholesterol and HDL-cholesterol measured before the lipid-lowering therapy (mean 14±6 months). Thus, we might have underestimated AFRS because differences might have existed between the lipid level associated with the time-gap between the initial lipid-lowering therapy and the study enrollment.
Fourth, we excluded patients with chronic kidney disease, which is one of the important risk factors of CHD; this could be a bias in this study. Because the AFRS did not include creatinine in its risk score formula, this might have underestimated the risk of CHD in patients with chronic kidney disease. However, the FMD and baPWV would be negatively affected by chronic kidney disease. 23, 24 Fifth, the Framingham risk score predicts hard CHD (angina pectoris, myocardial infarction and CHD death). However, this study excluded patients with acute coronary syndrome and we used CHD on CAG as an endpoint. Thus, generalization of our study findings to all the patients with chest pain is difficult.
Conclusion
AFRS was a better predictor for detecting CHD than either FMD or baPWV in patients with stable angina. This means that conventional risk factors for cardiovascular disease do not affect uniformly for atherosclerosis in coronary and peripheral arteries.
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